Literature DB >> 18363506

Expression strategies for short hairpin RNA interference triggers.

John J Rossi1.   

Abstract

Since the discovery that the triggers for RNA interference (RNAi), small interfering RNAs, could mediate silencing in mammalian cells without triggering a toxic response, RNAi has become the standard tool for sequence-specific knockdown of gene expression in molecular biology. This is due in part to the development of methods for promoter-based expression of RNAi triggers that can mediate stable silencing in mammalian cells. Numerous systems with slightly different characteristics exist, but despite incredible progress in a field that moves very rapidly, challenges still remain. The biggest challenge is to successfully and safely apply RNAi in vivo. Aside from potential issues of delivery, which is one of the most important considerations, successful application of short hairpin RNAs (shRNAs) in vivo requires expression systems that yield potent and specific knockdown of the target in the absence of toxicity. With a couple of exceptions, the current systems available for shRNA expression have not generally resulted in unexpected toxicities, while still providing strong knockdown of the intended targets; however, we do not know enough about how sequence-specific off-target effects will affect various cell and tissue types, or to what extent ectopic expression of RNAi triggers will perturb the endogenous RNAi mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363506      PMCID: PMC2702704          DOI: 10.1089/hum.2008.026

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  54 in total

1.  Stable suppression of gene expression by RNAi in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells.

Authors:  Yan Zeng; Eric J Wagner; Bryan R Cullen
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

3.  Gene silencing using micro-RNA designed hairpins.

Authors:  Michael T McManus; Christian P Petersen; Brian B Haines; Jianzhu Chen; Phillip A Sharp
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

4.  Effective expression of small interfering RNA in human cells.

Authors:  Cynthia P Paul; Paul D Good; Ira Winer; David R Engelke
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

5.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

7.  A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.

Authors:  Lars Aagaard; Mohammed Amarzguioui; Guihua Sun; Luis C Santos; Ali Ehsani; Hans Prydz; John J Rossi
Journal:  Mol Ther       Date:  2007-02-20       Impact factor: 11.454

8.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

9.  A microRNA in a multiple-turnover RNAi enzyme complex.

Authors:  György Hutvágner; Phillip D Zamore
Journal:  Science       Date:  2002-08-01       Impact factor: 47.728

10.  RNA interference in adult mice.

Authors:  Anton P McCaffrey; Leonard Meuse; Thu-Thao T Pham; Douglas S Conklin; Gregory J Hannon; Mark A Kay
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

View more
  13 in total

1.  Influence of silencing soluble epoxide hydrolase with RNA interference on cardiomyocytes apoptosis induced by doxorubicin.

Authors:  Guangsheng Du; Jiagao Lv; Li He; Yexin Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

2.  A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.

Authors:  Edwin H Yau; Mark C Butler; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2016-05-25       Impact factor: 3.467

Review 3.  Personalized cancer approach: using RNA interference technology.

Authors:  John Nemunaitis; Donald D Rao; Shi-He Liu; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

4.  A direct comparison of strategies for combinatorial RNA interference.

Authors:  Luke S Lambeth; Nick J Van Hateren; Stuart A Wilson; Venugopal Nair
Journal:  BMC Mol Biol       Date:  2010-10-11       Impact factor: 2.946

5.  Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors.

Authors:  Sheena Saayman; Patrick Arbuthnot; Marc S Weinberg
Journal:  Nucleic Acids Res       Date:  2010-06-04       Impact factor: 16.971

6.  Influence of osteopontin short hairpin RNA on the proliferation and activity of rat vascular smooth muscle cells.

Authors:  Shan Ye; Yumei Sun; Aigui Bie; Ying Zhou; Jiani Liu; Qigong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

Review 7.  Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.

Authors:  Lígia Catarina Gomes-da-Silva; Sérgio Simões; João Nuno Moreira
Journal:  Cell Mol Life Sci       Date:  2013-11-13       Impact factor: 9.261

Review 8.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

9.  Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs.

Authors:  Robert Jan Lebbink; Maggie Lowe; Theresa Chan; Htet Khine; Xiaoyin Wang; Michael T McManus
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

Review 10.  RNA and disease.

Authors:  Thomas A Cooper; Lili Wan; Gideon Dreyfuss
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.